Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients.
Authors | |
---|---|
Year of publication | 2022 |
Type | Article in Periodical |
Magazine / Source | LEUKEMIA & LYMPHOMA |
MU Faculty or unit | |
Citation | ĎURINÍKOVÁ, Anna, Adam FOLTA, Filip PARDY, Jan SVATOŇ, Marie DRNCOVÁ, Barbora WEINBERGEROVÁ, Petr CETKOVSKY, Zdeněk RÁČIL, Pavel JINDRA, Tomas SZOTKOWSKI, Pavel ZAK, Jiří MAYER and Ivana JEŽÍŠKOVÁ. Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients. LEUKEMIA & LYMPHOMA. ABINGDON: TAYLOR & FRANCIS LTD, 2022, vol. 63, No 13, p. 3237-3240. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2022.2116931. |
web | https://www.tandfonline.com/doi/abs/10.1080/10428194.2022.2116931?journalCode=ilal20 |
Doi | http://dx.doi.org/10.1080/10428194.2022.2116931 |
Keywords | RAS MUTATIONAMLGENE |
Attached files | |
Description | Oncogenic mutation in the NRAS are carried by 10-22% acute myeloid leukemia (AML) patients and represents one of the most commonly detected molecular aberrations in AML. |
Related projects: |